
Loading, please wait...

Loading, please wait...

Layered bismuth-based materials are emerging as powerful tools in modern medicine. These materials possess unique structural chemistry and versatile physicochemical properties. Furthermore, their tailorable nature makes them ideal for diverse biomedical applications. Researchers can now modulate these compounds at the atomic scale. Consequently, this allows for precise control over electronic bandgaps and polarization. Such structural engineering creates new opportunities for Indian clinicians in diagnostics and therapeutics.
Modern radiology benefits significantly from these material advancements. Specifically, bismuth offers a high atomic number that enables superior X-ray attenuation. Therefore, these materials serve as highly effective contrast agents for CT scans. Moreover, they provide a safer, non-toxic alternative to traditional lead-based technologies. Additionally, layered bismuth-based materials enhance the sensitivity of next-generation imaging sensors. This improvement allows for lower radiation doses during routine diagnostic procedures.
In addition to diagnostics, these materials transform modern cancer treatment. They exhibit excellent photothermal conversion efficiency under near-infrared light. This unique property allows for highly targeted ablation therapy in oncology. Furthermore, researchers utilize their large surface areas for efficient drug delivery systems. Consequently, this improves therapeutic efficacy while reducing systemic toxicity in patients. High-performance biosensors also rely on these materials to detect biomarkers with extreme precision. In summary, these compounds represent a major step forward for integrated biomedical systems.
The transition from laboratory research to clinical practice faces several technical challenges. However, the future of these materials remains extremely promising. Clinicians should monitor these developments closely as they mature. They will likely redefine imaging protocols and therapeutic strategies in the coming years. Ongoing research continues to refine their biocompatibility for long-term clinical use.
These materials have a high atomic number, which provides excellent X-ray attenuation. They are also generally considered less toxic than lead-based contrast agents.
They are used in photothermal therapy to convert light into heat, which destroys cancer cells. Additionally, they serve as efficient carriers for targeted drug delivery.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or a professional relationship. Refer to the latest local and national guidelines for clinical practice.
References
Xie H et al. Tailoring of Layered Bismuth-Based Materials: Advanced Functionalities for Environment, Energy, Photonics, Electronics, and Biomedicine. Adv Mater. 2026 May 27. doi: 10.1002/adma.73398. PMID: 42200348.
Shah Noor et al. Recent advances in bismuth-based heterojunction photocatalysts. Front Chem. 2026 Mar 19;14:1753678. doi: 10.3389/fchem.2026.1753678. PMID: 41970236.
Ghosh J, Hoye RLZ. Progress and opportunities in bismuth-based materials for X-ray detection. MRS Energy Sustain. 2025 Aug 25;12:233.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


A comprehensive review of layered bismuth-based materials and their revolutionary impact on medical imaging, oncology, and next-generation biosensing....
3 months ago

Explore the emerging role of Brixadi, an extended-release buprenorphine injection, for managing stimulant use disorder through kappa opioid receptor antagonism and steady plasma levels.
Today

A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today

Dendritic cells bridge innate and adaptive immunity in myocardial infarction. This review explores their pathological roles, circulating dynamics, novel tolerogenic interventions, and how standard cardiovascular medications modulate dendritic cells to improve post-infarction myocardial repair and patient outcomes.
Today

Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday

Atherosclerosis involves extensive glycometabolic reprogramming across immune and vascular cells. This review examines how glycolysis, the pentose phosphate pathway, and lactate-driven epigenetic shifts fuel plaque vulnerability, while highlighting novel therapeutic targets like PFKFB3 and LDHA.
Today